A national biobank to collect information and test samples relating to repeated traumatic brain injuries often associated with sport was launched on 22nd March 2022 in Australia, with New Zealand announcing its intention to establish a similar clinic and biobank. Chronic traumatic encephalopathy (CTE) is a form of dementia that results from repeated head injuries, and is…
Category: Uncategorised
Call For Evidence Consultation Launched For ABI Strategy
A Call for Evidence has been launched for the recently agreed cross departmental Government strategy for Acquired Brain Injury (ABI). The UK Acquired Brain Injury Forum (UKABIF) joined other brain injury charities and organisations and people with acquired brain injury at the House of Commons this week where the Minister of State for Care and…
WFNR Franz Gerstenbrand Award 2022
Brain Awareness Week – WFNR Franz Gerstenbrand Award 2022 now open for entries As we mark Brain Awareness Week, I’m delighted to announce that the World Federation for Neurorehabilitation (WFNR) Franz Gerstenbrand Award 2022 is now open, and we particularly encourage entries from individuals under the age of 35 years who are clinicians, researchers or…
Music Therapy strikes a chord with traumatised emergency workers
The Blue Light Symphony Orchestra (BLSO), in collaboration with Chroma, successfully completed a pilot project delivering group Music Therapy to emergency service workers to help them recover from traumatic experiences. Working with Surrey and Sussex Police, Surrey and East Sussex Fire and Rescue and Southeast Coast Ambulance Service, the project, a UK first, delivered a…
Copaxone® for use in breastfeeding mothers with RMS
Change to COPAXONE® (Glatiramer Acetate (GA)) Summary of Product Characteristics (SmPC) in breastfeeding is relevant for the Multiple Sclerosis (“MS”) community and provides information for neurologists and patients of the positive benefit/risk balance of use in breastfeeding Relapsing Multiple Sclerosis (RMS) is 2-3 times more likely to affect womeni, with diagnosis most common during childbearing years The SmPC update…
UCB announces positive data in myasthenia gravis with zilucoplan phase 3 study results
Positive topline results show the Phase 3 RAISE (NCT04115293) zilucoplan trial met primary and all key secondary endpoints in adults with generalised myasthenia gravis The results show a favourable safety profile and good tolerability UCB plans to proceed with zilucoplan regulatory submissions later this year Results follow recent positive topline data from the Phase…
Consistency in migraine days over course of Ajovy®
Analysis of consistency in migraine days over the course of a dosing regimen for AJOVY® (fremanezumab-vfrm) Injection published in Headache – Analysis assessed migraine days at the beginning and end of quarterly and monthly dosing intervals Results from a post hoc analysis of a long-term, open-label extension study assessing migraine days at the beginning and…
